scispace - formally typeset
R

Regine Schneider-Stock

Researcher at University of Erlangen-Nuremberg

Publications -  127
Citations -  9632

Regine Schneider-Stock is an academic researcher from University of Erlangen-Nuremberg. The author has contributed to research in topics: Cancer & Apoptosis. The author has an hindex of 37, co-authored 117 publications receiving 8024 citations. Previous affiliations of Regine Schneider-Stock include Otto-von-Guericke University Magdeburg & United Arab Emirates University.

Papers
More filters
Journal ArticleDOI

Guidelines for the use and interpretation of assays for monitoring autophagy

Daniel J. Klionsky, +1287 more
- 01 Apr 2012 - 
TL;DR: These guidelines are presented for the selection and interpretation of methods for use by investigators who aim to examine macroautophagy and related processes, as well as for reviewers who need to provide realistic and reasonable critiques of papers that are focused on these processes.
Journal Article

Thymoquinone extracted from black seed triggers apoptotic cell death in human colorectal cancer cells via a p53-dependent mechanism.

Hala Gali-Muhtasib, +6 more
- 01 Jan 2004 - 
TL;DR: In this article, the effects of thymoquinone (TQ) against HCT-116 human colon cancer cells and attempted to identify its potential molecular mechanisms of action.
Journal ArticleDOI

Thymoquinone extracted from black seed triggers apoptotic cell death in human colorectal cancer cells via a p53-dependent mechanism.

Hala Gali-Muhtasib, +6 more
- 01 Oct 2004 - 
TL;DR: The results indicate that TQ is antineoplastic and pro-apoptotic against colon cancer cell line HCT116, and the potential for using the agent TQ for the treatment of colon cancer is supported.
Journal ArticleDOI

Reactive oxygen species mediate thymoquinone-induced apoptosis and activate ERK and JNK signaling

Nahed El-Najjar, +8 more
- 01 Feb 2010 - 
TL;DR: Evidence is presented linking the pro-oxidant effects of TQ with its apoptotic effects in colon cancer and prove a protective role of MAPK.
Journal ArticleDOI

Thymoquinone: fifty years of success in the battle against cancer models.

Regine Schneider-Stock, +4 more
- 01 Jan 2014 - 
TL;DR: The current state of knowledge of TQ's adjuvant potential and in vivo antitumor activity is discussed and its ability to modulate the hallmarks of cancer is highlighted.